期刊文献+

血浆同型半胱氨酸水平对原发性高血压患者冠心病发生的相关性研究 被引量:10

Correlation research of plasma homocysteine level for occurrence of coronary heart disease in patients with essential hypertension
下载PDF
导出
摘要 目的 探讨血浆同型半胱氨酸水平对原发性高血压患者发生冠心病的预测价值.方法 选择2010年1月至2012年1月我院接受冠状动脉造影检查的原发性高血压患者251例,根据冠脉造影情况分为单纯高血压组(120例)和高血压合并冠心病组(131例).分析高血压患者血浆同型半胱氨酸水平,比较不同同型半胱氨酸水平患者冠心病的发病率,并通过Logistic回归分析原发性高血压患者发生冠心病的危险因素.结果 高血压合并冠心病组患者血浆同型半胱氨酸和低密度脂蛋白水平[(14.69±7.39) μmol/L,(3.14±0.22)mmol/L]高于单纯高血压组患者[(19.03±7.33)μmol/L,(3.37±0.34)mmol/L],而高密度脂蛋白水平[(1.31±0.38)mmol/L]低于单纯高血压组患者[(1.15±0.42)mmol/L],差异均有统计学意义(P=0.000,P=0.002,P=0.000).血浆同型半胱氨酸水平(OR =4.503,P=0.021)和低密度脂蛋白水平(OR =3.509,P=0.000)是原发性高血压患者发生冠心病的独立危险因素.高密度脂蛋白可以降低原发性高血压患者发生冠心病的风险(OR =0.439,P=0.012).结论 血浆同型半胱氨酸水平越高,原发性高血压患者发生冠心病的可能性越大. Objective To explore the value of homocysteine (Hey) in patients with essential hypertension to predict the occurrence of coronary heart disease (CHD). Methods Based on the results of coronary angiography, 251 patients with essential hypertension were divided into two groups as essential hypertension group (n=121) and essential hypertension with CHD group (n=130). Hcy level was analyzed in patients with essential hypertension and was used to evaluate the occurrence of CHD. The logistic regression model was used to analyze the risk factors for occurrence of CHD. Results The levels of Hey and low density lipoprotein-cholesterol [(14.69+7.39)lxmol/L, (3.14±0.22)mmol/L] in essential hypertension with CHD group were higher than that in essential hypertension group [(19.03 ±7.33)μmol/L, (3.37 ±0.34)mmol/L], while high density lipoproteincholesterol [(1.31 ±0.38)mmol/L] was lower than essential hypertension group [(1.15±0.42)mmol/L]. In the logistic regression model, the levels of homocysteine(P=0.019) and low density lipoprotein-eholesterol(P=0.028 ) were the independent predictors for occurrence of CHD in patients with essential hypertension, while high density lipoprotein-eholesterol can lower the occurrence of CHD in patients with essential hypertension (P=0.020). Conclusion The elevated level of Hey has the prognostic value for the occurrence of CHD in patients with essential hypertension.
出处 《中国心血管病研究》 CAS 2015年第10期913-916,共4页 Chinese Journal of Cardiovascular Research
关键词 高血压 冠状动脉疾病 同型半胱氨酸 Hypertension Coronary heart disease Homocysteine
  • 相关文献

参考文献22

  • 1Go AS, Mozaffarian D, Roger VL, et al. Executive summary:heart disease and stroke statistics: 2013 update : a report from theAmerican heart association. Circulation,2013,127: 143-146. 被引量:1
  • 2Roger VL, Go AS, Lloyd -Jones DM, et al. Heart disease andstroke statistics -2011 update a report from the American heartassociation. Circulation,2011,123 : 208-209. 被引量:1
  • 3Goldstein LB, Bushnell CD, Adams RJ, et al. Guidelines for theprimary prevention of stroke a guideline for health careprofessionals from the American heart association/American strokeassociation. Stroke,2011,42:517-584. 被引量:1
  • 4Clarke R, Halsey J, Bennett D, et al. Homocysteine and vascu-lar disease : review of published results of the homocysteine - low-ering trials. J Inhe Metab Dis,2011,34:83-91. 被引量:1
  • 5Sydow K, Boger RH. Reloaded: ADMA and oxidative stress areresponsible for endothelial dysfunction in hyperhomocyst (e) in-aemia: effects of 1-arginine and B vitamins. Cardiovascular Res,2012,96:167-171. 被引量:1
  • 6Kloppenborg RP, Nederkoom PJ, van der Graaf Y, et al. Homo-cysteine and cerebral small vessel disease in patients with symp-tomatic atherosclerotic disease. The Smart-MR study. Atheroscle-rosis,2011,216:461-466. 被引量:1
  • 7Tehlivets O. Homocysteine as a risk factor for atherosclerosis: isits conversion to s -adenosyl -L-homocysteine the key to deregu-lated lipid metabolism. Journal of lipids,2011 (2011) http://www.hindawi.com/joumals/jl/2011/702853/abs/. 被引量:1
  • 8Perla-Kajdn J, Twardowski T, Jakubowski H. Mechanisms of ho-mocysteine toxicity in humans. Am Acids, 2007,32 : 561 -572. 被引量:1
  • 9Smith DEC, Smulders YM, Blom HJ, et al. Determinants of theessential one - carbon metabolism metabolites, homocysteine, S-adenosylmethionine,S-adenosylhomocysteine and folate, in cere-brospinal fluid. Clin Chem Lab Med,2012,50: 1641-1647. 被引量:1
  • 10Rafeq Z, Roh JD, Guarino P, et al. Adverse myocardial effectsof B -vitamin therapy in subjects with chronic kidney diseaseand hyperhomocysteinaemia. Nutrition, Metabolism and Cardio-vascular Diseases, 2013,23 : 836-842. 被引量:1

二级参考文献21

  • 1任军梅,王瑞英,黄淑田.冠心病、高血压病患者脉压、C-反应蛋白和同型半胱氨酸相关性分析[J].中国心血管病研究,2004,2(7):504-507. 被引量:9
  • 2杨水祥,胡大一.心力衰竭的新机制和新策略研究进展[J].中国心血管病研究,2005,3(6):403-405. 被引量:53
  • 3刘伟峰,张步延,黄文增,关红菁.高同型半胱氨酸血症致血管炎症作用[J].中国动脉硬化杂志,2005,13(4):464-466. 被引量:32
  • 4Cesari M,Zanchetta M,Burlina A,et al.Hyperhomocysteinemia is inversely related with left ventricular ejection fraction and predicts cardiovascular mortality in high-risk coronary artery disease hypertensive.Arterioscler Thromb Vasc Biol J,2005,25:115-121. 被引量:1
  • 5Nygard O,Nordrehaug JE,Refsum H,et al.Plasma homocysteine levels and mortality in patients with coronary artery disease.N Engl J Med,1997,337:230-236. 被引量:1
  • 6Blacker J,Demuth K,Guerin AP,et al.Influence of biochemical alterations on arterial stiffness in patients with end-stage renal disease.Arterioscler Thromb Vasc Biol,1998,18:535-541. 被引量:1
  • 7Retterstol L,Paus B,Bohn M,et al.Plasma total homocysteine levels and prognosis in patients with previous premature myocardial infarction:a 10-year follow-up study.J Intern Med,2003,253:284-292. 被引量:1
  • 8Wilcken DE, Wilcken B. The pathogenesis of coronary artery dis- ease. A possible role for methionine metabolism. J Clin Invest, 1976,57:1079-1052. 被引量:1
  • 9陈健,张陆地,陈柏楠.同型半胱氨酸致动脉硬化机制的研究进展.中华中医药学会周围血管分会学术大会论文集(二).北京:中华中医药学会,2009. 被引量:1
  • 10Blake GJ, Ridker PM. Inflammatory biomarkers and cardiovascular risk prediction. Intern Med, 2002,252: 283-294. 被引量:1

共引文献4

同被引文献92

  • 1全国eGFR课题协作组.MDRD方程在我国慢性肾脏病患者中的改良和评估[J].中华肾脏病杂志,2006,22(10):589-595. 被引量:706
  • 2王辉宇.血清同型半胱氨酸检测在心血管疾病诊治中的应用[J].中国实用医刊,2015,42(3):33-34. 被引量:3
  • 3Vizzardi E,Nodari S,Fiorina C,et al.Plasma homocysteine levels and late outcome in patients with unstable angina[J].Cardiology,2007,107(4):354-359. 被引量:1
  • 4KIZILARSLANOGLU M C, KARA O, YESIL Y, et al. Alzheimer dis- ease, inflammation, and novel inflammatory marker : resistin [ J ]. Turkish Journal Of Medical Sciences,2015,45 (5) : 1040-1046. 被引量:1
  • 5LEE J O, KIM N, LEE H J, et al. Resistin, a fat-derived secretory factor, promotes metastasis of MDA-MB-231 human breast cancer ceils through ERM activation [ J ]. Sci Rep,2016,6:18923. doi: 10. 1038/srep18923. 被引量:1
  • 6GENCER B, AUER R, DE REKENEIRE N, et al. Association be- tween resistin levels and cardiovascular disease events in older a- dults:the health, aging and body composition study[ J]. Atheroscle- rosis,2016,245 : 181-186. doi : 10. 1016/j. atheroseclerosis. 2015. 12. 004. 被引量:1
  • 7ZAIDI S I, SHIRWANY T A. Relationship of serum resistin with in- sulin resistance and obesity[ J ]. J Ayub Med Coll Abbottabad,2016, 27(3) :552-555. 被引量:1
  • 8MAROUGA A, DALAMAGA M, KASTANIA A N, et al. Circulating resistin is a significant predictor of mortality independently from car- diovascular comorbidities in elderly, non-diabetic subjects with chro- nic kidney disease[J]. Biomarkers,2016,21 ( 1 ) :73-79. 被引量:1
  • 9HEILBRONN L K. Relationship between serum resistin concentratio- nand insulin resistance innon-obeseobese and obese diabetic subjects [ J ]. J Clin Endocrinol Metab,2004,89 : 1844-1848. 被引量:1
  • 10BADOER E, KOSARI S,STEBBING M J. Resistin, an adipokine with non-generalized actions on sympathetic nerve activity [ J ]. Front Physio1,2015,6:321. doi: 10. 3389/fphys. 2015. 00321. 被引量:1

引证文献10

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部